Real-time enrollment status for this relapsed or refractory follicular lymphoma clinical trial
Current Status
Recruiting
Checked: October 23, 2026 at 1:19 PM UTC
| NCT Number | NCT07343934 |
| Recruiting Status | Recruiting |
| Condition | Relapsed or Refractory Follicular Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 6 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Pennsylvania |
| Last Updated on CT.gov | September 16, 2026 (Sep 16, 2026) |
As of October 23, 2026: Clinical trial NCT07343934 is currently recruiting participants. This phase1 study for relapsed or refractory follicular lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Pennsylvania. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07343934 is actively recruiting participants as of October 23, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07343934 was last updated Sep 16, 2026 (September 16, 2026). HelloStudys verifies this status automatically.